🇺🇸 FDA
Patent

US 6555568

Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids

expired A61KA61K31/405A61K31/427

Quick answer

US patent 6555568 (Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids) held by The Institute for Pharmaceutical Discovery, L.L.C. expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Institute for Pharmaceutical Discovery, L.L.C.
Grant date
Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
49
CPC classes
A61K, A61K31/405, A61K31/427, A61K31/428, A61K31/4439